Cann Group Ltd Secures $2M Loan Facility Increase for Convertible Note Redemption
Cann Group secures $2 million increase to its Private Credit Loan Facility
Cann Group (ASX: CAN) has agreed with its private credit lender to increase the total commitment available under its existing Private Credit Loan Facility by $2 million, less establishment fees (the “Additional Commitment”). The arrangement was announced on 3 July 2026.
The increase is provided on the same terms as the existing facility, which the Company entered into as part of the debt restructure announced on 27 October 2025. Under those arrangements, the Additional Commitment may only be drawn for an agreed “Approved Purpose.”
Key details of the facility increase include:
-
Facility increase of $2 million (less establishment fees)
-
Provided on the same terms as the existing facility (27 October 2025 restructure)
-
Drawable only for an agreed “Approved Purpose”
When big ASX news breaks, our subscribers know first
What the funding will be used for
The Additional Commitment may only be drawn to fund specific purposes agreed between the Company and the Lender, with each such use defined as an “Approved Purpose.” The identified Approved Purpose is the early redemption of the Company’s convertible notes, including associated costs, as announced on 30 June 2026.
The convertible notes redemption, announced on 30 June 2026, retired all 350,000 remaining notes at face value, with the standard 5% early redemption premium waived by the lender, reducing the net cost of retiring the debt ahead of schedule.
| Detail | Figure / Term | Source Reference |
|---|---|---|
| Additional Commitment | $2M less establishment fees | 3 July 2026 |
| Facility terms | Same as existing facility | 27 Oct 2025 restructure |
| Approved Purpose | Early convertible note redemption | 30 June 2026 announcement |
Understanding private credit facilities
The next major ASX story will hit our subscribers first
How this fits Cann’s funding roadmap
The facility increase is consistent with the Company’s own guidance in its Quarterly Activities Report released 29 April 2026, which reported on Q3 FY26 (January to March 2026). In that report, Cann noted it was in discussions with its debt provider regarding further funding.
The latest arrangement follows through on that previously communicated intent, moving the earlier discussions to a firm agreement with the Lender.
Key statement
“This increase is consistent with the Company’s statement in its Quarterly Activities Report (released 29 April 2026) that it was in discussions with its debt provider regarding further funding.”
The announcement was authorised for release by the Board of Directors of Cann Group Limited.
Cann Group develops, produces and supplies medicinal cannabis products through its Botanitech and Mallee Bloom brands, operating from its large-scale cultivation and GMP manufacturing facility near Mildura, Victoria.
Stay Ahead on ASX Healthcare News
Big News Blast delivers FREE breaking ASX healthcare announcements directly to your inbox within minutes of release, complete with in-depth analysis. Join 20,000+ subscribers already getting the edge on market-moving news. Click the “Free Alerts” button at StockWire X to start receiving alerts the moment they drop.